Renaissance Venture Capital Fund recently made its first investment commitment from its Renaissance II fund. The commitment was made to Allos II, a Cincinnati and Indianapolis-based venture capital fund targeting investments in early-stage technology companies based in the Midwest. The fund’s investor group, which includes institutional investors such as Indiana University Foundation, Purdue University and […]
MEMBER PRESS RELEASE: Atterocor Launches Innovative Company Focused on Accelerated Development of Treatment for Adrenal Cancer; Secures $16 Million Series A Financing Life Sciences Investors Frazier Healthcare and 5AM Ventures Lead the Round Ann Arbor, Michigan – August 3, 2012 – Atterocor, Inc., a company developing an innovative therapy for adrenal cancer, today announced a […]